CD19/BCMA-Targeted UCAR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19/BCMA-Targeted UCAR-T, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases [EARLY_Phase 1]